John Ryan, MD

All posts by John Ryan, MD

September 7th, 2013

Visit-to-Visit Variability in Systolic BP Among Patients with Type 2 Diabetes

and

John Chalmers and his coauthors discuss their analysis of data from the ADVANCE trial.


September 6th, 2013

Early Surgery vs. Watchful Waiting for Flail-Leaflet Mitral Regurgitation

, and

Rakesh M. Suri and Maurice Enriquez-Sarano discuss their research group’s comparison of early mitral valve surgery with initial medical management among patients in the Mitral Regurgitation International Database.


September 5th, 2013

Rosiglitazone Revisited

and

Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.


September 3rd, 2013

For CRT, Let ECG — Not Echo — Be Your Guide

and

Clyde Yancy, coauthor of the NEJM editorial about the EchoCRT Study Group’s randomized trial of echocardiography-guided CRT, provides further insights about the findings.


September 1st, 2013

Inside the ACCOAST Trial of Pretreatment Prasugrel

, , and

Gilles Montalescot, lead investigator of the ACCOAST trial, discusses why prasugrel pretreatment did not benefit patients with non–ST-segment elevation acute coronary syndromes.


August 30th, 2013

Will New Scanner Technology Reduce Radiation from CT Angiography?

, and

Kavitha Chinnaiyan and Gilbert L. Raff discuss their study group’s nonrandomized investigation of using new scanner technology to reduce radiation from coronary CT angiography in the context of an ongoing quality-improvement program.


August 28th, 2013

Remote Ischemic Preconditioning for CABG: An Investigator’s Perspective

and

Gerd Heusch discusses his study group’s randomized trial of remote ischemic preconditioning before coronary artery bypass graft surgery.


August 5th, 2013

Putting the 2013 Heart Failure Guidelines Into Practice

, and

CardioExchange’s Harlan Krumholz and John Ryan interview Clyde W. Yancy, lead member of the ACCF/AHA task force that wrote the 2013 guidelines for management of heart failure. Krumholz and Ryan: What is the biggest challenge to implementing the heart failure guidelines for every patient with heart failure? Yancy: The biggest challenge is no longer in establishing “proof.” […]


July 25th, 2013

The Changing Landscape of Pulmonary Hypertension

Two multicenter clinical trials published in the New England Journal of Medicine explore the role of a new oral pulmonary vasodilator in pulmonary hypertension.


July 18th, 2013

BNP-Based Screening + Collaborative Care to Prevent Heart Failure?

and

Kenneth McDonald discusses findings from the STOP-HF randomized trial of BNP-based screening versus usual primary care for preventing new-onset heart failure.